Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.68% is 14% below its 5-year average of 0.79%, near the low end of its 5-year range (0.22%–2.11%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.81% below its 12-month average of 0.72%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.68%.
DEBT TO ASSETS RATIO
0.68%
DEBT TO ASSETS RATIO AVG TTM
0.72%
DEBT TO ASSETS RATIO AVG 3Y
0.80%
DEBT TO ASSETS RATIO AVG 5Y
0.79%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-4.81%
CURRENT VS 3Y AVG
-15.38%
CURRENT VS 5Y AVG
-13.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+656.41%
vs the sector median at left
Stoke Therapeutics, Inc.
Market Cap
$1.57B
Debt to Assets Ratio
0.68%
TTM Avg
0.72%
3Y Avg
0.80%
5Y Avg
0.79%
Market Cap
$1.59B
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.54B
Debt to Assets Ratio
0.84%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.61B
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.62B
Debt to Assets Ratio
0.76%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | $1.57B | 0.68% | 0.72% | 0.80% | 0.79% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | 0.22% | N/A | N/A | N/A |
| uniQure N.V. (QURE)vs › | $1.60B | 0.06% | N/A | N/A | N/A |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | 0.84% | N/A | N/A | N/A |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | 0.12% | N/A | N/A | N/A |
| Innoviva, Inc. (INVA)vs › | $1.54B | 0.16% | N/A | N/A | N/A |
| Septerna Inc (SEPN)vs › | $1.61B | 0.04% | N/A | N/A | N/A |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 0.10% | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | 0.76% | N/A | N/A | N/A |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 0.22% | N/A | N/A | N/A |
Debt/Assets
0.7%
Debt/Equity
0.01
Current Ratio
7.69
Interest Coverage
-2287.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.68% |
| 2026-03-31 | 0.77% |
| 2025-12-31 | 0.72% |
| 2025-09-30 | 0.81% |
| 2025-06-30 | 0.60% |
| 2025-03-31 | 0.58% |
| 2024-12-31 | 1.76% |
| 2024-09-30 | 0.78% |
| 2024-06-30 | 0.74% |
| 2024-03-31 | 1.08% |
| 2023-12-31 | 0.90% |
| 2023-09-30 | 1.04% |
| 2023-06-30 | 0.95% |
| 2023-03-31 | 0.85% |
| 2022-12-31 | 0.92% |
| 2022-09-30 | 0.83% |
| 2022-06-30 | 0.69% |
| 2022-03-31 | 0.49% |
| 2021-12-31 | 2.11% |
| 2021-09-30 | 2.10% |
| 2021-06-30 | 0.22% |
| 2021-03-31 | 0.01% |
| 2020-12-31 | 0.36% |
| 2020-09-30 | 0.56% |
| 2020-06-30 | 0.52% |
| 2020-03-31 | 0.48% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
